Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The reactivity of sinusoids in
hepatocellular carcinoma
(
HCC
), focal nodular hyperplasia, and nonneoplastic liver tissue with various endothelial markers was investigated to detect any differences that might be of diagnostic relevance. The lectin UEA-1 antibody BMA 120, and antibodies against von Willebrand's factor, CD31, and
CD34
were used. KP1 was employed to detect Kupffer cells. In the normal liver there was only focal staining of sinusoidal endothelium in the vicinity of the portal tracts with all of the endothelial markers applied. In the cirrhotic liver a slightly greater number of sinusoids (mainly in the vicinity of the fibrous septa) stained with UEA-1 and, although to a lesser extent, with anti-von Willebrand's factor and anti-CD31. A slight increase in staining for
CD34
was seen in only 1 of the 11 specimens of cirrhotic liver. In focal nodular hyperplasia, there was increased staining of sinusoids with all of the markers investigated; staining was confined mainly to the periphery of the nodules.
HCC
exhibited the most obvious differences in numbers of stained sinusoids and staining intensity in comparison with both normal and cirrhotic liver. UEA-1 and anti-
CD34
stained large numbers of sinusoids in virtually all of the
HCC
investigated; UEA-1 stained a slightly greater number of sinusoids and did so with slightly greater intensity. BMA 120 and the antibodies against von Willebrand's factor and CD31 stained a smaller number of sinusoids and did so with lower intensity; they failed to stain sinusoids in some of the tumors. Because staining of the sinusoids in cirrhotic liver was minimal with anti-
CD34
, this antibody proved to be the best of all the markers investigated for distinguishing highly differentiated
HCC
from nonneoplastic liver tissue. It seems possible that the increase in immunoreactivity of sinusoids in
HCC
with anti-CD, unlike that with Uea-1, anti-von Willebrand's factor, and anti-CD31, is not an expression of capillarization, but rather of angiogenesis.
...
PMID:Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. 753 28
gP130 transducing receptor is involved in the formation of high affinity receptors for the cytokines of the interleukin-6 (IL-6) family. Recruitment of gp130 by IL-6 associated to its receptor leads to the dimerization of the transducing component. In the present study we did characterize the B-S12 monoclonal antibody raised against gp130 and able to elicit IL-6 type biological activities. B-S12 antibody triggered strongly the proliferation of TF1 and XGI hematopoietic cell lines and was able to increase the synthesis of acute phase proteins in HepG2
hepatoma
cell line. B-S12 also behaved as a synergistic factor with granulocyte-macrophage colony-stimulating factor for both proliferation and differentiation of
CD34
-positive hematopoietic cell progenitors. By using a symmetric enzyme-linked immunosorbent assay, allowing the detection of dimeric forms of soluble gp130, we found that addition of B-S12 to gp130 led to its dimerization. Analysis of the tyrosine phosphorylation events in gp130 and Jak kinase family members revealed that B-S12 quickly induced the phosphorylation of gp130 in a neural derived cell line, and that Jak1 and Jak2 were also recruited. In conclusion, we show that gp130 cross-linking with the B-S12 monoclonal antibody was sufficient to generate functional IL-6 type responses in hematopoietic, neural, and hepatic cells.
...
PMID:gp130 transducing receptor cross-linking is sufficient to induce interleukin-6 type responses. 866 9
The immunohistochemical expression of
CD34
(human hematopoietic stem cell and endothelial cell marker) and laminin were studied in chronic liver diseases and
hepatocellular carcinoma
(
HCC
) to elucidate whether their expression reflected phenotypic differences between non-cancerous sinusoids and sinusoid-like tumor vessels. In normal liver, hepatic sinusoids were always negative for
CD34
and laminin. In chronic hepatitis and cirrhosis, the two antigens were sparsely expressed in capillarized sinusoids at periportal and perinodular area. In advanced
HCC
,
CD34
was strongly and diffusely expressed by the endothelial lining of sinusoid-like tumor vessels. However, early-stage
HCC
showed a wide spectrum of
CD34
expression from negative to focal and diffuse, strongly positive staining in sinusoid-like vessels. Laminin was strongly expressed in advanced
HCC
but not in early-stage
HCC
. The results indicate that the enhanced expression of
CD34
by sinusoidal endothelial cells may reflect the phenotypic change of endothelial cells in chronic liver diseases and
HCC
, and that the expression may correlate with the processes of angiogenesis induced by hepatocarcinogenesis.
...
PMID:Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma. 891 44
Angiogenesis is crucial for tumor growth and metastasis.
Hepatocellular carcinoma
(
HCC
) is a typical hypervascular tumor. However, the relationship between tumor vascularity and the outcome of patients with
HCC
has not been evaluated. To clarify whether tumor angiogenesis is related to the prognosis of patients, immunohistochemical staining, using anti-von Willebrand factor (vWF) and anti-
CD34
, was applied in resected specimens from 43 cases of
HCC
. In nonmalignant tissue, staining was confined to vessels in the portal tract and to a few periportal sinusoids with both of the endothelial markers applied. In tumor tissue, however, sinusoid-like vessels reacted intensively with anti-
CD34
but not with anti-vWF. The intratumor microvessel density (MVD) highlighted by anti-
CD34
was 297 +/- 88 (per 0.74 mm2), which was significantly higher than that highlighted by anti-vWF (4 +/- 7). When only the MVD highlighted by anti-
CD34
was analyzed, tumor diameter larger than 2 cm, poor differentiation (Edmondson's II to IV), and portal invasion were significantly related to the subgroup with MVD > or = 290. Overall survival curves of patients with MVD < 290 were better, and these patients were more likely to remain tumor free. Cox hazards model revealed intratumor MVD and Edmondson's grade to be independent prognostic factors for the overall survival of patients. These results demonstrated for the first time that tumor angiogenesis assessed by anti-
CD34
was correlated with the outcome of patients with
HCC
, suggesting a potential role for anti-
CD34
in the diagnosis and treatment of
HCC
.
...
PMID:Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. 936 65
To clarify the relationship between angiogenesis and hepatocarcinogenesis on progression of
hepatocellular carcinoma
(
HCC
), we quantitatively evaluated angiogenesis by
CD34
immunohistochemistry in liver cirrhosis (LC), adenomatous hyperplasia (AH), and
HCC
, and proliferative activity estimated by Ki-67 immunohistochemistry. Angiogenesis was evaluated by
CD34
immunohistochemistry using monoclonal antibody HPCA-2, and tumor proliferative activity was evaluated using monoclonal antibody MIB-1. We used an image analysis system to assess the microvessel density as the area percentage of the endothelial area. Angiogenesis was generally observed in
HCC
and there was no significant difference among all clinical stages and histological grades of
HCC
. On the other hand, the staining of
CD34
was partly observed in sinusoids of AH, although no positive staining was seen in any sinusoids of LC. The proliferative activity was significantly correlated with the clinical stage and histological grade of
HCC
. Our results indicate that the quantitation of angiogenesis does not provide significant prognostic information in
HCC
, but that it may have diagnostic value in distinguishing
HCC
from non-
HCC
. Meanwhile, AH, which is not morphologically diagnosed as cancer, shows positive staining for
CD34
, suggesting that some portion of AH contains cancerous characteristics.
...
PMID:Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry. 954 62
The blood supply of
hepatocellular carcinoma
(
HCC
) is primarily arterial. Recent studies reported differences of vascular, especially arterial, supply among low- and high-grade dysplastic nodules and
HCC
. We assessed arterialization using monoclonal antibody specific for smooth muscle actin as well as simultaneous changes in sinusoidal capillarization in cirrhotic nodules, dysplastic nodules, and
HCC
. We immunohistochemically stained 56 cirrhotic nodules, 20 low-grade dysplastic nodules, 27 high-grade dysplastic nodules, and 20 HCCs for alpha smooth muscle actin (to identify unpaired arteries (i.e., arteries not accompanied by bile ducts) and
CD34
(indicating sinusoidal capillarization). Distribution and number of unpaired arteries and distribution of sinusoidal capillarization were graded semiquantitatively. Unpaired arteries were rare in cirrhotic nodules, significantly more common in dysplastic nodules of both types (p < 0.00001), and most common in
HCC
. Sinusoidal capillarization was least common in cirrhotic nodules, significantly more common in dysplastic nodules (p < 0.0035), and most common in
HCC
. No topographic relationship between unpaired arteries and sinusoidal capillarization was identified. These findings showed that (1) distributions of sinusoidal capillarization and unpaired arteries in dysplastic nodules are intermediate between those in cirrhotic nodules and
HCC
, supporting dysplastic nodules as premalignant lesions; (2) unpaired arteries are histologically useful for distinguishing dysplastic nodules from large cirrhotic nodules; and (3) areas of sinusoidal capillarization within dysplastic nodules are unrelated to location of arterialization.
...
PMID:Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. 963 Jan 72
Improved imaging techniques have led to an increased detection of suspicious "nodules" in the cirrhotic and noncirrhotic liver. Although the histologic diagnosis of clearly benign or clearly malignant lesions is usually straightforward, problems arise in the differential diagnosis of benign "nodules" and dysplastic lesions or well-differentiated hepatocellular carcinomas. This is especially so in limited diagnostic material, such as cytologic preparations from fine-needle aspirates and needle-core tissue biopsies. Recently, additional helpful markers have been described that may help to establish a conclusive diagnosis even on such material. Two of these, the reticulin stain and immunohistochemical staining for
CD34
, have been found to be useful also in cytologic cellblock material. Telomerase, a complex enzyme that is active in most malignant tumors, has also been found to show strong activity in most hepatocellular carcinomas. Mention is made of an immunohistochemical marker (MOC-31), reported to be useful in the differentiation between metastatic adenocarcinoma and
hepatocellular carcinoma
.
...
PMID:Biopsy diagnosis of malignant versus benign liver "nodules": new helpful markers. An update. 1090 8
Platelet-derived endothelial cell growth factor (PD-ECGF), identical to thymidine phosphorylase, has been reported as an angiogenic factor in human malignancies. However, the role of PD-ECGF in human
hepatocellular carcinoma
(
HCC
) is still unconfirmed. Herein, we studied the expression of PD-ECGF in 27 human
HCC
cases by immunohistochemistry, to clarify the relationship to tumor angiogenesis. The immunoreaction of PD-ECGF in
HCC
cells was scored in both the staining percentage and intensity.
CD34
, an endothelial cell marker, was used to evaluate the intratumoral microvessel density (IMVD). PD-ECGF expression was noted in carcinoma cells in 14 (51.9%) of 27 HCCs. In these cases, the carcinoma cells showed heterogeneous staining in both the nucleus and cytoplasm. Tumor-associated stroma cells and infiltrating lymphocytes were also stained. Kupffer cells in non-tumor areas were strongly positive. Statistically, the expression of PD-ECGF increased in
HCC
specimens with high Edmondson grades (III-IV) or portal vein tumor thrombosis (PVTT) (P<0.05). Additionally, the IMVD of PD-ECGF-positive
HCC
specimens (136.071+/-31.008, mean +/- SD) was higher than that of the PD-ECGF-negative
HCC
specimens (61.077+/-15.795) (P<0.05). These findings may suggest that PD-ECGF is one of the angiogenic factors in human HCCs. Furthermore, with the increasing expression of PD-ECGF,
HCC
cells show poor differentiation and invasive behavior.
...
PMID:Increased expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high Edmondson grades and portal vein tumor thrombosis. 1141 Aug 1
Iron is essential for cell proliferation, heme synthesis, and a variety of cellular metabolic processes. In most cells, transferrin receptor-mediated endocytosis is a major pathway for cellular iron uptake. Recently, transferrin receptor 2 (TfR2), another receptor for transferrin, was cloned. High levels of expression of TfR2 messenger RNA (mRNA) occur in the liver, as well as in HepG2 (a
hepatoma
cell line) and K562 (an erythroid leukemia cell line). In this study, TfR2 mRNA expression was analyzed in hematological cell lines, normal erythroid cells at various stages of differentiation, and leukemia and preleukemia cells. High levels of TfR2 expression occurred in all of the erythroid cell lines that were examined. Erythroid-specific expression of TfR2 protein in bone marrow cells was confirmed by immunohistochemical staining. Expression of TfR2 mRNA was high in normal
CD34
(+) erythroid precursor cells, and levels decreased during erythroid differentiation in vitro. Levels of expression of TfR2-alpha mRNA were significantly higher in erythroleukemia (M6) marrow samples than in nonmalignant control marrow samples. In addition, relatively higher levels of TfR2-alpha mRNA expression occurred in some samples of myelodysplastic syndrome that had erythroid hyperplasia in bone marrow, acute myelogenous leukemia M1, M2, and chronic myelogenous leukemia. Expression profiles of normal members of the erythroid lineage suggest that TfR2-alpha may be a useful marker of early erythroid precursor cells. The clinical significance of TfR2-alpha expression in leukemia cells remains to be determined.
...
PMID:Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. 1167 42
Assessment of angiogenesis may yield important information for an effective antiangiogenic treatment for
hepatocellular carcinoma
(
HCC
) because
HCC
is characteristically hypervascular We examined the relationship of microvessel density (MVD), vascular endothelial growth factor (VEGF), and VEGF receptors Flt-1 and Flk-1/KDR in 50 patients with
HCC
and in 3
hepatoma
cell lines. VEGF messenger RNA (mRNA) was overexpressed in 26 tumors (52%), and the 3 VEGF isoforms (121, 165, and 189) were present in high frequencies. Flt-1 mRNA was overexpressed in 34 tumors (68%), with levels significantly increased in HCCs compared with the nontumorous livers. Tumor Flt-1 mRNA significantly correlated with tumor VEGF mRNA levels. Within the group of tumors 8.5 cm or less in diameter, tumors with intrahepatic metastasis in the form of tumor microsatellite formation had significantly higher VEGF mRNA levels. MVD assessed by immunohistochemical analysis with
CD34
antibody was inversely related to tumor size. Angiogenesis as assessed by MVD and tumor VEGF expression seems to have a more important role in tumor growth and intrahepatic metastasis in smaller HCCs. The differential up-regulation of Flt-1 suggests that it may have an important role in angiogenesis in
HCC
.
...
PMID:Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. 1176 72
1
2
3
4
5
6
7
8
9
10
Next >>